Serological testing after infusion confirmed the absence of anti-N antibodies and the presence of anti-S only with neutralizing effect confirmed by Mesoscale discovery COVID-19 ACE2 competition assay, with results ranging from absent at baseline to >100% after first and second infusions (Table S3). Here, ACE2 is linked to COVID-19.